Core Specialty files U.S. IPO as nine-month revenue declines
Specialty insurer Core Specialty Insurance Holdings is moving ahead with a U.S. initial public offering while reporting weaker top-line performance for the first nine months of 2026. The filing comes as the property and casualty insurer posts lower revenue, net income and net premiums written from a year earlier, despite an improvement in underwriting profitability.
Highlights
- Core Specialty Insurance Holdings files for a U.S. IPO to list shares on the NYSE under the symbol 'CORE', with offering terms undisclosed.
- For the nine months ended September 30, net income drops to $68.8 million from $111.8 million as revenue declines to $2.16 billion from $2.55 billion.
- Combined ratio improves to 93% from 98.2% year-over-year, while net premiums written fall to $2.23 billion and investment income rises by about $20 million.
Filing outlines earnings and listing plan
As reported by Reuters, Core Specialty Insurance Holdings says it has filed for an initial public offering in the United States and plans to list its shares on the New York Stock Exchange under the ticker symbol "CORE". The filing does not disclose the terms of the offering.For the nine months ended September 30, the company reports net income applicable to shareholders of $68.8 million on total revenue of $2.16 billion. That compares with net income of $111.8 million on revenue of $2.55 billion in the year-earlier period.
Net premiums written in the first nine months of 2026 come in at $2.23 billion, down from $2.61 billion a year earlier. Investment income edges up by about $20 million in the reported period.
Underwriting metrics and deal advisers
The insurer says its combined ratio improves to 93% from 98.2% a year earlier, a metric that indicates better underwriting performance when lower. Core Specialty operates across three specialty lines within the property and casualty insurance market.J.P. Morgan, Goldman Sachs & Co LLC and BMO Capital Markets are serving as book-running managers on the offering. The IPO adds another insurance listing candidate to the U.S. equity pipeline, though the company has not yet set a price range or fundraising target.
The latest update follows our earlier article on Kraken IPO access offered via its xStocks platform for the company behind Claude AI.